Cargando…

Oocyte aging is controlled by mitogen‐activated protein kinase signaling

Oogenesis is one of the first processes to fail during aging. In women, most oocytes cannot successfully complete meiotic divisions already during the fourth decade of life. Studies of the nematode Caenorhabditis elegans have uncovered conserved genetic pathways that control lifespan, but our knowle...

Descripción completa

Detalles Bibliográficos
Autores principales: Achache, Hanna, Falk, Roni, Lerner, Noam, Beatus, Tsevi, Tzur, Yonatan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208789/
https://www.ncbi.nlm.nih.gov/pubmed/34061407
http://dx.doi.org/10.1111/acel.13386
_version_ 1783708991740706816
author Achache, Hanna
Falk, Roni
Lerner, Noam
Beatus, Tsevi
Tzur, Yonatan B.
author_facet Achache, Hanna
Falk, Roni
Lerner, Noam
Beatus, Tsevi
Tzur, Yonatan B.
author_sort Achache, Hanna
collection PubMed
description Oogenesis is one of the first processes to fail during aging. In women, most oocytes cannot successfully complete meiotic divisions already during the fourth decade of life. Studies of the nematode Caenorhabditis elegans have uncovered conserved genetic pathways that control lifespan, but our knowledge regarding reproductive aging in worms and humans is limited. Specifically, little is known about germline internal signals that dictate the oogonial biological clock. Here, we report a thorough characterization of the changes in the worm germline during aging. We found that shortly after ovulation halts, germline proliferation declines, while apoptosis continues, leading to a gradual reduction in germ cell numbers. In late aging stages, we observed that meiotic progression is disturbed and crossover designation and DNA double‐strand break repair decrease. In addition, we detected a decline in the quality of mature oocytes during aging, as reflected by decreasing size and elongation of interhomolog distance, a phenotype also observed in human oocytes. Many of these altered processes were previously attributed to MAPK signaling variations in young worms. In support of this, we observed changes in activation dynamics of MPK‐1 during aging. We therefore tested the hypothesis that MAPK controls oocyte quality in aged worms using both genetic and pharmacological tools. We found that in mutants with high levels of activated MPK‐1, oocyte quality deteriorates more rapidly than in wild‐type worms, whereas reduction of MPK‐1 levels enhances quality. Thus, our data suggest that MAPK signaling controls germline aging and could be used to attenuate the rate of oogenesis quality decline.
format Online
Article
Text
id pubmed-8208789
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82087892021-06-25 Oocyte aging is controlled by mitogen‐activated protein kinase signaling Achache, Hanna Falk, Roni Lerner, Noam Beatus, Tsevi Tzur, Yonatan B. Aging Cell Original Articles Oogenesis is one of the first processes to fail during aging. In women, most oocytes cannot successfully complete meiotic divisions already during the fourth decade of life. Studies of the nematode Caenorhabditis elegans have uncovered conserved genetic pathways that control lifespan, but our knowledge regarding reproductive aging in worms and humans is limited. Specifically, little is known about germline internal signals that dictate the oogonial biological clock. Here, we report a thorough characterization of the changes in the worm germline during aging. We found that shortly after ovulation halts, germline proliferation declines, while apoptosis continues, leading to a gradual reduction in germ cell numbers. In late aging stages, we observed that meiotic progression is disturbed and crossover designation and DNA double‐strand break repair decrease. In addition, we detected a decline in the quality of mature oocytes during aging, as reflected by decreasing size and elongation of interhomolog distance, a phenotype also observed in human oocytes. Many of these altered processes were previously attributed to MAPK signaling variations in young worms. In support of this, we observed changes in activation dynamics of MPK‐1 during aging. We therefore tested the hypothesis that MAPK controls oocyte quality in aged worms using both genetic and pharmacological tools. We found that in mutants with high levels of activated MPK‐1, oocyte quality deteriorates more rapidly than in wild‐type worms, whereas reduction of MPK‐1 levels enhances quality. Thus, our data suggest that MAPK signaling controls germline aging and could be used to attenuate the rate of oogenesis quality decline. John Wiley and Sons Inc. 2021-06-01 2021-06 /pmc/articles/PMC8208789/ /pubmed/34061407 http://dx.doi.org/10.1111/acel.13386 Text en © 2021 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Achache, Hanna
Falk, Roni
Lerner, Noam
Beatus, Tsevi
Tzur, Yonatan B.
Oocyte aging is controlled by mitogen‐activated protein kinase signaling
title Oocyte aging is controlled by mitogen‐activated protein kinase signaling
title_full Oocyte aging is controlled by mitogen‐activated protein kinase signaling
title_fullStr Oocyte aging is controlled by mitogen‐activated protein kinase signaling
title_full_unstemmed Oocyte aging is controlled by mitogen‐activated protein kinase signaling
title_short Oocyte aging is controlled by mitogen‐activated protein kinase signaling
title_sort oocyte aging is controlled by mitogen‐activated protein kinase signaling
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208789/
https://www.ncbi.nlm.nih.gov/pubmed/34061407
http://dx.doi.org/10.1111/acel.13386
work_keys_str_mv AT achachehanna oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling
AT falkroni oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling
AT lernernoam oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling
AT beatustsevi oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling
AT tzuryonatanb oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling